Categories

Tag: INDICAID Respiratory Portfolio

PHASE Scientific Launches FebriDx Test in U.S. Market

PHASE Scientific Launches FebriDx Test in U.S. Market

Introduction of FebriDx will enhance PHASE Scientific’s INDICAID portfolio and strengthen its leadership in point-of-care respiratory diagnostics.  PHASE Scientific, a fast-growing biotech company known for its